Analysis of gene expression in subpopulations of murine hematopoietic stem and progenitor cells

Experimental Hematology

Volumn 28, Issue 3, 2000, Pages 318-334

  Zinovyeva, Marina V ^a,b   Zijlmans, J Mark J M ^c   Fibbe, Willem E ^c   Visser, Jan W M ^b   Belyavsky, Alexander V ^a,b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b NEW YORK BLOOD CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell cycle; Differentiation; Gene expression; Molecular markers; Stem cells

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MARKER GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; DNA, COMPLEMENTARY; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MICE;

MURINAE;

EID: 0034108274     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00158-7     Document Type: Article

References (68)

1. Visser J.W., de Vries P., Hogeweg-Platenburg M.G., Bayer J., Schoeters G., van den Heuvel R., Mulder D.H. Culture of hematopoietic stem cells purified from murine bone marrow. Semin Hematol. 28:1991;117.
2. Morrison S.J., Uchida N., Weissman I.L. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 11:1995;35.
3. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science. 241:1988;58.
4. Spangrude G.J., Scollay R. A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol. 18:1990;920.
5. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 273:1996;242.
6. Bertoncello I., Hodgson G.S., Bradley T.R. Multiparameter analysis of transplantable hematopoietic stem cells. I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence Exp Hematol. 13:1985;999.
7. Visser J.W., De Vries P. Identification and purification of murine hematopoietic stem cells by flow cytometry. Methods Cell Biol. 33:1990;451.
8. Li C.L., Johnson G.R. Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells. J Exp Med. 175:1992;1443.
9. Wolf N.S., Kone A., Priestley G.V., Bartelmez S.H. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342- rhodamine 123 FACS selection. Exp Hematol. 21:1993;614.
10. Zijlmans JM, Visser JW, Kleiverda K, Kluin PM, Willemze R, Fibbe WE (1995) Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability: Proc Natl Acad Sci U S A 92:8901.
11. Zijlmans J.M., Visser J.W., Laterveer L., Kleiverda K., Heemskerk D.P., Kluin P.M., Willemze R., Fibbe W.E. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci U S A. 95:1998;725.
12. Berardi A.C., Wang A., Levine J.D., Lopez P., Scadden D.T. Functional isolation and characterization of human hematopoietic stem cells. Science. 267:1995;104.
13. Goodell M.A., Rosenzweig M., Kim H., Marks D.F., DeMaria M., Paradis G., Grupp S.A., Sieff C.A., Mulligan R.C., Johnson R.P. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 3:1997;1337.
14. Orlic D., Anderson S., Biesecker L.G., Sorrentino B.P., Bodine D.M. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-Myb and low levels or no colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A. 92:1995;4601.
15. Cheng T., Shen H., Giokas D., Gere J., Tenen D.G., Scadden D.T. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc Natl Acad Sci U S A. 93:1996;13158.
16. Testa U., Fossati C., Samoggia P., Masciulli R., Mariani G., Hassan H.J., Sposi N.M., Guerriero R., Rosato V., Gabbianelli M., Pelosi E., Valtieri M., Peschle C. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood. 88:1996;3391.
17. Brady G., Billia F., Knox J., Hoang T., Kirsch I.R., Voura E.B., Hawley R.G., Cumming R., Buchwald M., Siminovitch K., Miyamoto N., Boehmelt G., Iscove N.N. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol. 5:1995;909.
18. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:1997;774.
19. Scollay R., Wilson A., D'Amico A., Kelly K., Egerton M., Pearse M., Wu L., Shortman K. Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol Rev. 104:1988;81.
20. Matsuzaki Y., Gyotoku J., Ogawa M., Nishikawa S., Katsura Y., Gachelin G., Nakauchi H. Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J Exp Med. 178:1993;1283.
21. Loffert D., Schaal S., Ehlich A., Hardy R.R., Zou Y.R., Muller W., Rajewsky K. Early B-cell development in the mouse. insights from mutations introduced by gene targeting Immunol Rev. 137:1994;135.
22. Loken M.R., Shah V.O., Dattilio K.L., Civin C.I. Flow cytometric analysis of human bone marrow. II. Normal erythroid development. Blood. 69:1987;255.
23. Ivanova N.B., Belyavsky A.V. Identification of differentially expressed genes by restriction endonuclease-based gene expression fingerprinting. Nucleic Acids Res. 23:1995;2954.
24. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A Laboratory Manual. Plainview: Cold Spring Harbor Lab Press.
26. Zinovyeva M.V., Popsueva A.E., Ershler M.A., Belyavsky A.V., Visser J.W., Zijlmans J.M., Fibbe W.E. Identification of genes, predominantly expressed during early stages of murine hemopoiesis. Dokl Akad Nauk. 344:1995;256.
27. Zaki S.R., Austin G.E., Swan D.C., Hooper W.C., Greer P.W., Evatt B.L., Chan W.C. Studies of myeloperoxidase gene expression at the cellular level by in situ hybridization. Leukemia. 4:1990;813.
28. Shirsat N.V., Bittenbender S., Kreider B.L., Rovera G. Structure of the murine lactotransferrin gene is similar to the structure of other transferrin-encoding genes and shares a putative regulatory region with the murine myeloperoxidase gene. Gene. 110:1992;229.
29. Aveskogh M., Lutzelschwab C., Huang M.R., Hellman L. Characterization of cDNA clones encoding mouse proteinase 3 (myeloblastine) and cathepsin G. Immunogenetics. 46:1997;181.
30. Lagasse E, Weissman IL (1992) Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. Blood 79:1907.
31. Popsueva A.E., Zinovyeva M.V., Visser J.W., Zijlmans J.M., Fibbe W.E., Belyavsky A.V. A novel murine cathelin-like protein expressed in bone marrow. FEBS Lett. 391:1996;5.
32. Sanchez M.J., Muench M.O., Roncarolo M.G., Lanier L.L., Phillips J.H. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 180:1994;569.
33. Morgan D.O. Cyclin-dependent kinases. engines, clocks, and microprocessors Annu Rev Cell Dev Biol. 13:1997;261.
34. Arellano M., Moreno S. Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol. 29:1997;559.
35. Harper J.W., Elledge S.J. Cdk inhibitors in development and cancer. Curr Opin Genet Dev. 6:1996;56.
36. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 8:1996;205.
37. Orkin S.H. Transcription factors and hematopoietic development. J Biol Chem. 270:1995;4955.
38. Pevny L., Simon M.C., Robertson E., Klein W.H., Tsai S.F., D'Agati V., Orkin S.H., Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:1991;257.
39. Tsai F.Y., Keller G., Kuo F.C., Weiss M., Chen J., Rosenblatt M., Alt F.W., Orkin S.H. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 371:1994;221.
40. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47.
41. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., Pietryga D.W., Scott W.J. Jr., Potter S.S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:1991;677.
42. Georgopoulos K., Moore D.D., Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science. 258:1992;808.
43. Shibanuma M., Kuroki T., Nose K. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J Biol Chem. 267:1992;10219.
44. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12:1998;982.
45. Martin D.I., Zon L.I., Mutter G., Orkin S.H. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 344:1990;444.
46. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285.
47. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609.
48. Kane S.E., Pastan I., Gottesman M.M. Genetic basis of multidrug resistance of tumor cells. J Bioenerg Biomembr. 22:1990;593.
49. Krause D.S., Fackler M.J., Civin C.I., May W.S. CD34. structure, biology, and clinical utility Blood. 87:1996;1.
50. Desiderio S.V., Yancopoulos G.D., Paskind M., Thomas E., Boss M.A., Landau N., Alt F.W., Baltimore D. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature. 311:1984;752.
51. dull+ hematopoietic progenitor cells in murine bone marrow. Blood. 81:1993;3217.
52. Chellappan S.P., Giordano A., Fisher P.B. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol. 227:1998;57-103.
53. Welch P.J., Wang J.Y. Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc Natl Acad Sci U S A. 89:1992;3093.
54. Pines J., Hunter T. Isolation of a human cyclin cDNA. evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 Cell. 58:1989;833.
55. Hannon G.J., Beach D. p15INK4b is a potential effector of cell cycle arrest mediated by TGFβ Nature. 371:1994;257.
56. Elbendary A., Berchuck A., Davis P., Havrilesky L., Bast R.C. Jr., Iglehart J.D., Marks J.R. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1994;1301.
57. Furukawa Y. Cell cycle regulation of hematopoietic stem cells. Hum Cell. 11:1998;81.
58. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 9:1997;180.
59. Smith M.J., Prochownik E.V. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood. 79:1992;2107.
60. Ravitz M.J., Wenner C.E. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res. 71:1997;165.
61. Gewirtz A.M., Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science. 242:1988;1303.
62. Bhalla K., Ibrado A.M., Tourkina E., Tang C., Grant S., Bullock G., Huang Y., Ponnathpur V., Mahoney M.E. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 82:1993;3133.
63. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R.T., Remotti H., Stevens J.L., Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12:1998;982.
64. Ploemacher R.E., Brons N.H. Cells with marrow and spleen repopulating ability and forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine 123 retention. J Cell Physiol. 136:1988;531.
65. Chaudhary P.M., Roninson I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 66:1991;85.
66. Bunting K.D., Galipeau J., Topham D., Benaim E., Sorrentino B. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cells expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood. 92:1998;2269.
67. Sato T., Laver J., Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 94:1999;2548.
68. Morel F., Galy A., Chen B., Szilvassy S.J. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34- fractions of Thy-1lowLin-/lowSca-1+ bone marrow cells. Exp Hematol. 26:1998;440.